ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
4.875
-0.475 (-8.88%)
At close: Nov 20, 2024, 4:00 PM
4.850
-0.025 (-0.51%)
Pre-market: Nov 21, 2024, 7:42 AM EST
ImmunityBio Employees
ImmunityBio had 628 employees as of December 31, 2023. The number of employees decreased by 97 or -13.38% compared to the previous year.
Employees
628
Change (1Y)
-97
Growth (1Y)
-13.38%
Revenue / Employee
$11,675
Profits / Employee
-$935,978
Market Cap
3.40B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 628 | -97 | -13.38% |
| Dec 31, 2022 | 725 | 138 | 23.51% |
| Dec 31, 2021 | 587 | 322 | 121.51% |
| Dec 31, 2019 | 265 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BrightSpring Health Services | 35,000 |
| Acadia Healthcare Company | 23,500 |
| Envista Holdings | 12,800 |
| Neogen | 2,917 |
| PTC Therapeutics | 1,055 |
| Apellis Pharmaceuticals | 706 |
| Denali Therapeutics | 445 |
| Rhythm Pharmaceuticals | 226 |
IBRX News
- 1 day ago - ImmunityBio, Inc. Investor Alert (NASDAQ: IBRX): Schubert Jonckheer & Kolbe LLP Investigating Potential Shareholder Claims Against the Company's Officers and Directors for Possible False Statements - PRNewsWire
- 2 days ago - ImmunityBio Completes ANKTIVA's Post-Approval Enrollment of the 100th Patient in BCG Unresponsive NMIBC CIS Trial and Reports a Complete Response Rate of 71% with a Durable Duration of Response Ranging Up to 54 Months - Business Wire
- 9 days ago - ImmunityBio Reports Third-Quarter 2024 Financial Results - Business Wire
- 24 days ago - ImmunityBio: CAR-NK Cell Therapy Data For NHL Expected In Second Half Of 2025 - Seeking Alpha
- 27 days ago - Top 2 Health Care Stocks That May Fall Off A Cliff This Month - Benzinga
- 4 weeks ago - First Patients Dosed in Phase 1 Clinical Study of ImmunityBio's CAR-NK Cell Therapy for the Treatment of Relapsed B-Cell Non-Hodgkin Lymphoma - Business Wire
- 4 weeks ago - 800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio - Benzinga
- 4 weeks ago - ImmunityBio to Participate in the Jefferies London Healthcare Conference - Business Wire